Reumatoloxía

2003

1. Aproximación al coste del tratamiento farmacológico en la artritis reumatoide en España

   Anales de medicina interna, Vol. 20, Núm. 3, pp. 114-121

2. Aproximación al coste del tratamiento farmacológico en la artritis reumatoide en España

   Anales de Medicina Interna, Vol. 20, Núm. 3, pp. 114-121

3. Artritis séptica recidivante por Staphylococcus lugdunensis sobre prótesis de rodilla

   Enfermedades infecciosas y microbiologia clinica, Vol. 21, Núm. 4

4. Audiovestibular manifestations in giant cell arteritis: A prospective study

   Medicine, Vol. 82, Núm. 1, pp. 13-26

5. Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: Study of seven cases

   HIV Clinical Trials, Vol. 4, Núm. 2, pp. 132-136

6. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility

   Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382

7. Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir

   AIDS Patient Care and STDs, Vol. 17, Núm. 9, pp. 443-445

8. Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from Northwest Spain

   Journal of Rheumatology, Vol. 30, Núm. 5, pp. 913-917

9. Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study

   Arthritis Care and Research, Vol. 49, Núm. 1, pp. 64-70

10. Cutaneous vasculitis: A diagnostic approach

    Clinical and Experimental Rheumatology, Vol. 21, Núm. 6 SUPPL. 32

11. Drosophila melanogaster and the Future of 'Evo-Devo' Biology in Space. Challenges and Problems in the Path of an Eventual Colonization Project Outside the Earth

    Advances in Space Biology and Medicine, Vol. 9, pp. 41-81

12. Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 30, Núm. 9, pp. 2019-2022

13. Fatal Kikuchi-Fujimoto disease: The lupus connection

    Annals of Hematology, Vol. 82, Núm. 3, pp. 186-188

14. Fatigue Fractures Suggesting Clinical Monarthritis

    Arthritis Care and Research, Vol. 49, Núm. 6, pp. 741-744

15. First-line therapy and mitochondrial damage: Different nucleosides, different findings

    HIV Clinical Trials, Vol. 4, Núm. 1, pp. 11-19

16. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica

    Seminars in Arthritis and Rheumatism, Vol. 33, Núm. 1, pp. 38-48

17. Genética de la artrosis

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 4, Núm. 1, pp. 35-46

18. Gynecomastia in HIV-infected patients receiving antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 9, pp. 739-741

19. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis

    American Journal of Medicine, Vol. 114, Núm. 8, pp. 647-652

20. Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy

    HIV Clinical Trials, Vol. 4, Núm. 6, pp. 361-371